What is GCAT?

GCAT is 20,000 people participating in the same biomedical research project to help researchers answer important questions about our health and the treatment of illnesses.

GCAT|Genomes for Life, A Prospective Study of the Genomes of Catalonia is a very ambitious biomedical research project with scientific, medical and social implications.   It will study the genetic and environmental factors that lead to the appearance of chronic illnesses in the population.  Most of these illnesses, such as cancer, diabetes, cardiovascular disease or respiratory disease affect a large part of the population and are the most usual causes of death; they represent a huge cost to the health system because of their chronic nature.

Stakeholders

The GCAT Project has been designed with the support of national public institutions and counting on the collaboration of the public of Catalonia as the main interested party.

Our stakeholders are:

• The population of Catalonia
• Program for Predictive and Personalized Medicine of Cancer at the Germans Trias i Pujol Research Institute (PMPPC-IGTP)
• The Germans Trias Research Institute (IGTP)
• The Blood and Tissue Bank of Catalonia (BST)
• The Catalan Agency for Evaluation and Quality in Health (AQuAS)

Financial Support

The PMPPC-IGTP has put the GCAT project into action with the close collaboration of the Blood and Tissue Bank of Catalonia (BST) with the full support of the Directorate General of Research and Innovation and the Ministry of Health of the Generalitat of Catalonia.

The initial phases of the project have been supported by the Ministry of Health, Social Services and Equality of Spain and the Ministry of Health of the Generalitat of Catalonia via competitive public funding from the "Sub-Programme of Revitalizing Actions in the Research and Technology Environment" of the SNS.2010 (ADE10/00026, FIS).